abcam

abcam

Biotechnology Research

Cambridge, Cambridgeshire 50,986 followers

About us

At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.

Website
https://www.abcam.com/
Industry
Biotechnology Research
Company size
1,001-5,000 employees
Headquarters
Cambridge, Cambridgeshire
Type
Public Company
Specialties
antibodies, custom services, proteins, gene-edited cell lines, knockout cell lines, rabbit antibodies, immunoassays, biological reagents, monoclonal antibodies, research, drug discovery , diagnostics, RabMAb, and Life Sciences

Locations

Employees at abcam

Updates

Affiliated pages

Similar pages

Browse jobs

Funding

abcam 3 total rounds

Last Round

Post IPO equity

US$ 256.9M

Investors

HSBC
See more info on crunchbase